Towards novel anti-cancer strategies based on cystatin function
- PMID: 15893421
- DOI: 10.1016/j.canlet.2005.04.001
Towards novel anti-cancer strategies based on cystatin function
Abstract
Cystatins have recently emerged as important players in a multitude of physiological and patho-physiological settings that range from cell survival and proliferation, to differentiation, cell signaling and immunomodulation. This group of cysteine protease inhibitors forms a large super-family of proteins composed of one, two, three, and, in some species, more than three cystatin domains. Over the last 20 years or so, members of the cystatin super-family have been primarily explored with respect to their capacity to inhibit intracellular cysteine proteases. Yet, this classical mode of action does not fully explain their remarkably diverse biological functions. Due to the space limitations, the author will discuss here the most recent findings that suggest that some of the single-domain, cytoplasmic and cell-secreted cystatins may play important roles in the promotion or suppression of tumor growth, invasion and metastasis. Based on the present understanding of cystatin function, novel avenues for anti-cancer strategies are proposed.
Similar articles
-
Cystatins--Extra- and intracellular cysteine protease inhibitors: High-level secretion and uptake of cystatin C in human neuroblastoma cells.Biochimie. 2010 Nov;92(11):1625-34. doi: 10.1016/j.biochi.2010.08.011. Epub 2010 Aug 25. Biochimie. 2010. PMID: 20800088
-
Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression.Biol Chem Hoppe Seyler. 1995 Feb;376(2):71-80. Biol Chem Hoppe Seyler. 1995. PMID: 7794528 Review.
-
Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis.Oncol Rep. 2006 Oct;16(4):647-55. Oncol Rep. 2006. PMID: 16969475
-
Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain.Biol Chem. 2001 Jan;382(1):97-107. doi: 10.1515/BC.2001.015. Biol Chem. 2001. PMID: 11258679
-
Role of cystatins in tumor neovascularization.Future Oncol. 2005 Oct;1(5):661-72. doi: 10.2217/14796694.1.5.661. Future Oncol. 2005. PMID: 16556043 Review.
Cited by
-
Attenuation of the transforming growth factor beta-signaling pathway in chronic venous ulcers.Mol Med. 2010 Mar;16(3-4):92-101. doi: 10.2119/molmed.2009.00149. Epub 2010 Jan 6. Mol Med. 2010. PMID: 20069132 Free PMC article.
-
Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy.Anal Cell Pathol (Amst). 2016;2016:4918325. doi: 10.1155/2016/4918325. Epub 2016 Dec 18. Anal Cell Pathol (Amst). 2016. PMID: 28078200 Free PMC article.
-
VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation.Cancer Res. 2009 May 15;69(10):4537-44. doi: 10.1158/0008-5472.CAN-08-4539. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435903 Free PMC article.
-
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia.Cancers (Basel). 2020 Sep 26;12(10):2766. doi: 10.3390/cancers12102766. Cancers (Basel). 2020. PMID: 32993115 Free PMC article.
-
Developmental regulation of synthesis and dimerization of the amyloidogenic protease inhibitor cystatin C in the hematopoietic system.J Biol Chem. 2014 Apr 4;289(14):9730-40. doi: 10.1074/jbc.M113.538041. Epub 2014 Feb 25. J Biol Chem. 2014. PMID: 24570004 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous